c‐MYC and p53 expression highlight starry‐sky pattern as a favourable prognostic feature in R‐CHOP‐treated diffuse large B‐cell lymphoma

Diffuse large B‐cell lymphoma (DLBCL) is a clinically heterogeneous entity, in which the first‐line treatment currently consists of an immuno‐chemotherapy regimen (R‐CHOP). However, around 30% of patients will not respond or will relapse. Overexpression of c‐MYC or p53 is frequently found in DLBCL,...

Descripción completa

Detalles Bibliográficos
Autores principales: Bouroumeau, Antonin, Bussot, Lucile, Bonnefoix, Thierry, Fournier, Cyril, Chapusot, Caroline, Casasnovas, Olivier, Martin, Laurent, McLeer, Anne, Col, Edwige, David‐Boudet, Laurence, Lefebvre, Christine, Algrin, Caroline, Raskovalova, Tatiana, Jacob, Marie‐Christine, Vettier, Claire, Chevalier, Simon, Callanan, Mary B, Gressin, Rémy, Emadali, Anouk, Sartelet, Hervé
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8503894/
https://www.ncbi.nlm.nih.gov/pubmed/34374220
http://dx.doi.org/10.1002/cjp2.223

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8503894/
https://www.ncbi.nlm.nih.gov/pubmed/34374220
http://dx.doi.org/10.1002/cjp2.223

Ejemplares similares